491 related articles for article (PubMed ID: 22076431)
21. Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain.
DaSilva I; Huerta A; Quintana L; Redondo B; Iglesias E; Draibe J; Praga M; Ballarín J; Díaz-Encarnación M;
BioDrugs; 2017 Jun; 31(3):239-249. PubMed ID: 28534103
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of children with steroid-dependent nephrotic syndrome with rituximab].
Huang J; Du J; Wang S; Xiao L; Zhao X
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):521-4. PubMed ID: 25224058
[TBL] [Abstract][Full Text] [Related]
23. Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome.
Basu B; Preussler S; Sander A; Mahapatra TKS; Schaefer F
BMC Nephrol; 2020 Nov; 21(1):520. PubMed ID: 33256621
[TBL] [Abstract][Full Text] [Related]
24. Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome.
Kemper MJ; Kuwertz-Broeking E; Bulla M; Mueller-Wiefel DE; Neuhaus TJ
Nephrol Dial Transplant; 2004 May; 19(5):1136-41. PubMed ID: 14993510
[TBL] [Abstract][Full Text] [Related]
25. Rituximab for steroid-dependent nephrotic syndrome.
Beco A; Castro-Ferreira I; Coentrao L; Neto R; Sampaio S; Pestana M
Clin Nephrol; 2010 Oct; 74(4):308-10. PubMed ID: 20875384
[TBL] [Abstract][Full Text] [Related]
26. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
Ponticelli C; Edefonti A; Ghio L; Rizzoni G; Rinaldi S; Gusmano R; Lama G; Zacchello G; Confalonieri R; Altieri P
Nephrol Dial Transplant; 1993; 8(12):1326-32. PubMed ID: 8159300
[TBL] [Abstract][Full Text] [Related]
27. Steroid-sensitive nephrotic syndrome: from childhood to adulthood.
Fakhouri F; Bocquet N; Taupin P; Presne C; Gagnadoux MF; Landais P; Lesavre P; Chauveau D; Knebelmann B; Broyer M; Grünfeld JP; Niaudet P
Am J Kidney Dis; 2003 Mar; 41(3):550-7. PubMed ID: 12612977
[TBL] [Abstract][Full Text] [Related]
28. Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center.
Cartin-Ceba R; Golbin JM; Keogh KA; Peikert T; Sánchez-Menéndez M; Ytterberg SR; Fervenza FC; Specks U
Arthritis Rheum; 2012 Nov; 64(11):3770-8. PubMed ID: 22730028
[TBL] [Abstract][Full Text] [Related]
29. Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results.
Medeot M; Zaja F; Vianelli N; Battista M; Baccarani M; Patriarca F; Soldano F; Isola M; De Luca S; Fanin R
Eur J Haematol; 2008 Sep; 81(3):165-9. PubMed ID: 18510702
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome.
Tellier S; Brochard K; Garnier A; Bandin F; Llanas B; Guigonis V; Cailliez M; Pietrement C; Dunand O; Nathanson S; Bertholet-Thomas A; Ichay L; Decramer S
Pediatr Nephrol; 2013 Jun; 28(6):911-8. PubMed ID: 23340857
[TBL] [Abstract][Full Text] [Related]
31. Early high-dose immunosuppression in Henoch-Schönlein nephrotic syndrome may improve outcome.
Andersen RF; Rubak S; Jespersen B; Rittig S
Scand J Urol Nephrol; 2009; 43(5):409-15. PubMed ID: 19921987
[TBL] [Abstract][Full Text] [Related]
32. Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.
Hino S; Takemura T; Okada M; Murakami K; Yagi K; Fukushima K; Yoshioka K
Am J Kidney Dis; 1998 Jun; 31(6):932-9. PubMed ID: 9631836
[TBL] [Abstract][Full Text] [Related]
33. Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency: comparison of daily and every-other-day usage.
Fu LS; Shien CY; Chi CS
Nephron Clin Pract; 2004; 97(4):c137-41. PubMed ID: 15331936
[TBL] [Abstract][Full Text] [Related]
34. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
Ueda N; Takahashi K; Akioka Y; Morooka M; Ogawa A; Tsuzuki K
J Nephrol; 2009; 22(5):610-5. PubMed ID: 19809993
[TBL] [Abstract][Full Text] [Related]
35. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.
Terrier B; Launay D; Kaplanski G; Hot A; Larroche C; Cathébras P; Combe B; de Jaureguiberry JP; Meyer O; Schaeverbeke T; Somogyi A; Tricot L; Zénone T; Ravaud P; Gottenberg JE; Mariette X; Cacoub P
Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1787-95. PubMed ID: 20740617
[TBL] [Abstract][Full Text] [Related]
37. Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias.
Rao A; Kelly M; Musselman M; Ramadas J; Wilson D; Grossman W; Shenoy S
Pediatr Blood Cancer; 2008 Apr; 50(4):822-5. PubMed ID: 17570702
[TBL] [Abstract][Full Text] [Related]
38. Relapse of nephrotic syndrome during post-rituximab peripheral blood B-lymphocyte depletion.
Sato M; Kamei K; Ogura M; Ishikura K; Ito S
Clin Exp Nephrol; 2018 Feb; 22(1):110-116. PubMed ID: 28434126
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab.
Kamei K; Ishikura K; Sako M; Aya K; Tanaka R; Nozu K; Kaito H; Nakanishi K; Ohtomo Y; Miura K; Takahashi S; Morimoto T; Kubota W; Ito S; Nakamura H; Iijima K;
Pediatr Nephrol; 2017 Nov; 32(11):2071-2078. PubMed ID: 28664242
[TBL] [Abstract][Full Text] [Related]
40. Treatment of steroid resistant nephrotic syndrome in children.
Kari JA; Halawani M
Saudi J Kidney Dis Transpl; 2010 May; 21(3):484-7. PubMed ID: 20427873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
